Dr. Goodman is a physician-scientist. He is a hematologist, medical oncologist and clinical researcher at CCCN. He participates in various basic, translational and clinical research studies at the practice. His translational research projects center around understanding mechanisms that govern cancers resistance to hormonal therapy, focusing on prostate cancer. His area of interests include: Genitourinary Malignancies (prostate, kidney, bladder and testicular cancers) and Clinical Research